360 related articles for article (PubMed ID: 18564011)
21. Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea.
Flores J; DuPont HL; Paredes-Paredes M; Aguirre-Garcia MM; Rojas A; Gonzalez A; Okhuysen PC
Clin Vaccine Immunol; 2010 May; 17(5):879-81. PubMed ID: 20219880
[TBL] [Abstract][Full Text] [Related]
22. Development of vaccines against cholera and diarrhoea due to enterotoxigenic Escherichia coli: memorandum from a WHO meeting.
Bull World Health Organ; 1990; 68(3):303-12. PubMed ID: 2203550
[TBL] [Abstract][Full Text] [Related]
23. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial.
Clemens JD; Sack DA; Harris JR; Chakraborty J; Neogy PK; Stanton B; Huda N; Khan MU; Kay BA; Khan MR
J Infect Dis; 1988 Aug; 158(2):372-7. PubMed ID: 3042876
[TBL] [Abstract][Full Text] [Related]
24. Recent progress toward an enterotoxigenic Escherichia coli vaccine.
Svennerholm AM; Lundgren A
Expert Rev Vaccines; 2012 Apr; 11(4):495-507. PubMed ID: 22551034
[TBL] [Abstract][Full Text] [Related]
25. Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea.
Steffen R; Castelli F; Dieter Nothdurft H; Rombo L; Jane Zuckerman N
J Travel Med; 2005; 12(2):102-7. PubMed ID: 15996455
[No Abstract] [Full Text] [Related]
26. Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
Harro C; Louis Bourgeois A; Sack D; Walker R; DeNearing B; Brubaker J; Maier N; Fix A; Dally L; Chakraborty S; Clements JD; Saunders I; Darsley MJ
Vaccine; 2019 Mar; 37(14):1978-1986. PubMed ID: 30797634
[TBL] [Abstract][Full Text] [Related]
27. Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae.
Chen WH; Garza J; Choquette M; Hawkins J; Hoeper A; Bernstein DI; Cohen MB
Clin Vaccine Immunol; 2015 Jan; 22(1):129-35. PubMed ID: 25410205
[TBL] [Abstract][Full Text] [Related]
28. Protective immunity of a Multivalent Vaccine Candidate against piglet diarrhea caused by enterotoxigenic Escherichia coli (ETEC) in a pig model.
Zhang H; Xu Y; Zhang Z; You J; Yang Y; Li X
Vaccine; 2018 Jan; 36(5):723-728. PubMed ID: 29287679
[TBL] [Abstract][Full Text] [Related]
29. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
30. Oral immunization of a live attenuated Escherichia coli strain expressing a holotoxin-structured adhesin-toxoid fusion (1FaeG-FedF-LTA₂:5LTB) protected young pigs against enterotoxigenic E. coli (ETEC) infection.
Ruan X; Zhang W
Vaccine; 2013 Mar; 31(11):1458-63. PubMed ID: 23375979
[TBL] [Abstract][Full Text] [Related]
31. Travelers' diarrhea.
Hill DR; Beeching NJ
Curr Opin Infect Dis; 2010 Oct; 23(5):481-7. PubMed ID: 20683261
[TBL] [Abstract][Full Text] [Related]
32. Antibodies derived from an enterotoxigenic Escherichia coli (ETEC) adhesin tip MEFA (multiepitope fusion antigen) against adherence of nine ETEC adhesins: CFA/I, CS1, CS2, CS3, CS4, CS5, CS6, CS21 and EtpA.
Nandre RM; Ruan X; Duan Q; Sack DA; Zhang W
Vaccine; 2016 Jun; 34(31):3620-5. PubMed ID: 27228947
[TBL] [Abstract][Full Text] [Related]
33. Status of vaccine research and development for enterotoxigenic Escherichia coli.
Bourgeois AL; Wierzba TF; Walker RI
Vaccine; 2016 Jun; 34(26):2880-2886. PubMed ID: 26988259
[TBL] [Abstract][Full Text] [Related]
34. Oral cholera vaccines: use in clinical practice.
Hill DR; Ford L; Lalloo DG
Lancet Infect Dis; 2006 Jun; 6(6):361-73. PubMed ID: 16728322
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
[TBL] [Abstract][Full Text] [Related]
36. New vaccines against bacterial enteric infections.
Holmgren J; Svennerholm AM
Scand J Infect Dis Suppl; 1990; 70():149-56. PubMed ID: 2287897
[TBL] [Abstract][Full Text] [Related]
37. Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli.
Sack RB; Santosham M; Froehlich JL; Medina C; Orskov F; Orskov I
Am J Trop Med Hyg; 1984 May; 33(3):460-6. PubMed ID: 6375407
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of a travelers' diarrhea vaccine system in travelers to India.
Steffen R; Cramer JP; Burchard G; Jelinek T; Schwarz U; Ramdas P; Chatterjee S; Jiang ZD; DuPont HL; Dewasthaly S; Westritschnig K; Behrens RH
J Travel Med; 2013; 20(6):374-9. PubMed ID: 24165382
[TBL] [Abstract][Full Text] [Related]
39. [Vaccines inf the prevention of fecal hazards].
Saliou P
Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):445-9. PubMed ID: 10078383
[TBL] [Abstract][Full Text] [Related]
40. Implications and measurement of herd protection (indirect effects) for enteric vaccine development.
Wierzba TF
Vaccine; 2019 Aug; 37(34):4775-4777. PubMed ID: 31358237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
